Cancer Therapy, MRI & Isotope Production

Advanced Oncotherapy (AVO) is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. AVO focuses on the development of a proprietary proton therapy system called Linac Image Guided Hadron Technology (LIGHT). This LIGHT system accelerates protons to the energy levels achieved in legacy machines but in a unit that is a quarter of the size and between a quarter and a fifth of the cost.

The objective is to maximise the destructive effect of radiation on tumours whilst minimising damage to healthy tissues. Treatment with protons is used when tumours are located near vital organs when other forms of radiation may be less effective or the side effect risk is too high.

AVO has chosen ScandiNova’s K100 modulator together with a klystron from Toshiba. ScandiNova’s patented pulsed power technology creates a proton beam with higher accuracy than traditional techniques, thus allowing better precision and more successful treatments of cancer patients. The controllable pulse will make it easier to obtain the exact proton position and exact dose required. In this way, each treatment session take less time and more patients can be treated.

LIGHT System video